Polyurethane scaffolds seeded with genetically engineered skeletal myoblasts: A promising tool to regenerate myocardial function

Artificial Organs

Volumn 34, Issue 2, 2010, Pages

  Blumenthal, Britta ^a   Golsong, Peter ^a   Poppe, Annika ^a   Heilmann, Claudia ^a   Schlensak, Christian ^a   Beyersdorf, Friedhelm ^a   Siepe, Matthias ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cell transplantation; Cytokines; Gene therapy; Myocardial infarction; Scaffold

Indexed keywords

CARDIOLOGY; CYTOLOGY; ELECTROPHORESIS; GENE THERAPY; POLYMERASE CHAIN REACTION; POLYURETHANES; RATS; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE;

CARDIAC FUNCTIONS; CELL TRANSPLANTATION; CYTOKINES; GROWTH FACTOR; IN-VIVO; MYOBLASTS; MYOCARDIAL FUNCTION; MYOCARDIAL INFARCTION; POLYURETHANE SCAFFOLDS; SKELETAL MYOBLASTS;

TISSUE REGENERATION;

DNA; POLYURETHAN; PROTEIN KINASE B; SCATTER FACTOR; STROMAL CELL DERIVED FACTOR 1; TISSUE SCAFFOLD; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL BASED GENE THERAPY; CELL EXPANSION; CELL ISOLATION; CONTROLLED STUDY; DNA TRANSFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; GENETIC ENGINEERING; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE CAPILLARY; HEART MUSCLE INJURY; LEWIS RAT; MYOBLAST; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; WESTERN BLOTTING;

ANIMALIA; RATTUS;

EID: 77149145864     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2009.00937.x     Document Type: Article

References (31)

1. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 2001 33 : 907 21.
2. Reinecke H, Murry CE. Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. J Mol Cell Cardiol 2002 34 : 251 3.
3. Menasche P. Skeletal myoblasts as a therapeutic agent. Prog Cardiovasc Dis 2007 50 : 7 17.
4. Aharinejad S, Abraham D, Paulus P, et al. Colony-stimulating factor-1 transfection of myoblasts improves the repair of failing myocardium following autologous myoblast transplantation. Cardiovasc Res 2008 79 : 395 404.
5. Elmadbouh I, Haider HK, Jiang S, Idris NM, Lu G, Ashraf M. Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium. J Mol Cell Cardiol 2007 42 : 792 803.
6. Haider HK, Ye L, Jiang S, et al. Angiomyogenesis for cardiac repair using human myoblasts as carriers of human vascular endothelial growth factor. J Mol Med 2004 82 : 539 49.
7. Retuerto MA, Schalch P, Patejunas G, et al. Angiogenic pretreatment improves the efficacy of cellular cardiomyoplasty performed with fetal cardiomyocyte implantation. J Thorac Cardiovasc Surg 2004 127 : 1041 9.
8. Yau TM, Kim C, Li G, Zhang Y, Weisel RD, Li RK. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 2005 112 : 123 8.
9. Azarnoush K, Maurel A, Sebbah L, et al. Enhancement of the functional benefits of skeletal myoblast transplantation by means of coadministration of hypoxia-inducible factor 1alpha. J Thorac Cardiovasc Surg 2005 130 : 173 9.
10. Mangi AA, Noiseux N, Kong D, et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003 9 : 1195 201.
11. Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 2004 44 : 654 60.
12. Kutschka I, Chen IY, Kofidis T, et al. Collagen matrices enhance survival of transplanted cardiomyoblasts and contribute to functional improvement of ischemic rat hearts. Circulation 2006 114 : I167 73.
13. Reffelmann T, Dow JS, Dai W, Hale SL, Simkhovich BZ, Kloner RA. Transplantation of neonatal cardiomyocytes after permanent coronary artery occlusion increases regional blood flow of infarcted myocardium. J Mol Cell Cardiol 2003 35 : 607 13.
14. Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001 7 : 430 6.
15. Murry CE, Reinecke H, Pabon LM. Regeneration gaps: observations on stem cells and cardiac repair. J Am Coll Cardiol 2006 47 : 1777 85.
16. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci U S A 2003 100 : 7808 11.
17. Pouzet B, Vilquin JT, Hagege AA, et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized? Circulation 2000 102 : 210 5.
18. Gisselfalt K, Edberg B, Flodin P. Synthesis and properties of degradable poly(urethane urea)s to be used for ligament reconstructions. Biomacromolecules 2002 3 : 951 8.
19. Siepe M, Giraud MN, Liljensten E, et al. Construction of skeletal myoblast-based polyurethane scaffolds for myocardial repair. Artif Organs 2007 31 : 425 33.
20. Siepe M, Giraud MN, Pavlovic M, et al. Myoblast-seeded biodegradable scaffolds to prevent post-myocardial infarction evolution toward heart failure. J Thorac Cardiovasc Surg 2006 132 : 124 31.
21. Gavira JJ, Perez-Ilzarbe M, Abizanda G, et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovasc Res 2006 71 : 744 53.
22. Ghostine S, Carrion C, Souza LC, et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002 106 : 131 6.
23. Pouzet B, Ghostine S, Vilquin JT, et al. Is skeletal myoblast transplantation clinically relevant in the era of angiotensin-converting enzyme inhibitors? Circulation 2001 104 : 223 8.
24. Suzuki K, Murtuza B, Suzuki N, Smolenski RT, Yacoub MH. Intracoronary infusion of skeletal myoblasts improves cardiac function in doxorubicin-induced heart failure. Circulation 2001 104 : I213 7.
25. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999 286 : 2244 5.
26. Takahashi A, Kureishi Y, Yang J, et al. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol 2002 22 : 4803 14.
27. Hedman M, Hartikainen J, Syvanne M, et al. Safety and feasibility of catheter-based local intracoronary vascular endothelial growth factor gene transfer in the prevention of postangioplasty and in-stent restenosis and in the treatment of chronic myocardial ischemia: phase II results of the Kuopio Angiogenesis Trial (KAT). Circulation 2003 107 : 2677 83.
28. Ma J, Ge J, Zhang S, et al. Time course of myocardial stromal cell-derived factor 1 expression and beneficial effects of intravenously administered bone marrow stem cells in rats with experimental myocardial infarction. Basic Res Cardiol 2005 100 : 217 23.
29. Tambara K, Premaratne GU, Sakaguchi G, et al. Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation 2005 112 : I129 I34.
30. Siepe M, Akhyari P, Lichtenberg A, Schlensak C, Beyersdorf F. Stem cells used for cardiovascular tissue engineering. Eur J Cardiothorac Surg 2008 34 : 242 7.
31. Menasche P, Alfieri O, Janssens S, et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008 117 : 1189 200.